In this video

Share

Biogen alzheimer's drug shows positive results

CNBC's Meg Tirrell reports the latest on Biogen's new alzheimer's drug slowing disease progression and Sarepta Therapeutics' latest muscular dystrophy drug trial.
03:08
Wed, Jul 25 20183:58 PM EDT